Fresh analysis reveals that people who discontinue popular GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who stop traditional diet and exercise regimens.
Published data in a leading health publication shows that while obese individuals can lose substantial amounts of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Individuals buying these drugs should be cognizant of the risk of quick weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight within about a year and a half.
Comparing Treatments
The study, which looked at dozens of studies involving over 9,000 of patients, compared the results of GLP-1 agonists with conventional dieting.
Researchers emphasize that individuals who shed pounds through dieting usually see a slower weight regain—approximately 0.1 kg a month—after stopping.
The Reason for the Rapid Rebound
Nutrition scientists believe the mechanism of the injections accounts for the accelerated regain.
The injections mimic a body's own chemical called GLP-1, which moderates hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement leads to hunger is no longer kept in check, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines suggest the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts argue that, considering the likelihood of relapse, the treatment should be considered ongoing.
This view is supported by drug manufacturers, who note that the findings "emphasize the chronic character of obesity," similar to managing conditions like hypertension.
Patient Testimonies
Users who have come off the jabs describe a intense return of cravings.
"It felt as if something that goes on and I was suddenly starving," recalled one woman.
This difficulty is exacerbated if patients have not established permanent dietary or behavioural changes during therapy.
Widespread Adoption
Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Use is more common among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are powerful tools for shedding pounds, they are not a permanent solution and long-term success hinges on integrated lifestyle changes.
